https://www.lupus.org/news/ifnalpha-kinoid-continues-to-be-studied-for-treatment-of-systemic-lupus-erythematosus
IFNalpha Kinoid Continues to be Studied for Treatment of Systemic Lupus Erythematosus
www.LupusTreatmentReport.com
https://www.lupus.org/news/ifnalpha-kinoid-continues-to-be-studied-for-treatment-of-systemic-lupus-erythematosus
IFNalpha Kinoid Continues to be Studied for Treatment of Systemic Lupus Erythematosus
https://globenewswire.com/news-release/2018/12/11/1664824/0/en/Neovacs-and-Centurion-Pharma-continue-their-collaboration-in-Lupus-based-on-the-results-of-the-Phase-IIb-trial-with-IFNalpha-Kinoid.html
Neovacs and Centurion Pharma continue their collaboration in Lupus based on the results of the Phase IIb trial with IFNalpha Kinoid